ID: ALA3605189

Max Phase: Preclinical

Molecular Formula: C24H35NO5

Molecular Weight: 417.55

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)CN1C[C@]2(CC[C@@]3(C)[C@@H](CC[C@@H]4[C@@H]3CC[C@]3(C)C(=O)CC[C@@H]43)C2)OC1=O

Standard InChI:  InChI=1S/C24H35NO5/c1-22-10-11-24(14-25(21(28)30-24)13-20(27)29-3)12-15(22)4-5-16-17-6-7-19(26)23(17,2)9-8-18(16)22/h15-18H,4-14H2,1-3H3/t15-,16-,17-,18-,22-,23-,24+/m0/s1

Standard InChI Key:  CMALEMUUAWRIGO-JRHAUIGTSA-N

Associated Targets(Human)

LAPC4 305 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Testosterone 17-beta-dehydrogenase 3 232 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 417.55Molecular Weight (Monoisotopic): 417.2515AlogP: 3.96#Rotatable Bonds: 2
Polar Surface Area: 72.91Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.70CX LogD: 3.70
Aromatic Rings: 0Heavy Atoms: 30QED Weighted: 0.64Np Likeness Score: 1.53

References

1. Djigoué GB, Kenmogne LC, Roy J, Maltais R, Poirier D..  (2015)  Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3.,  23  (17): [PMID:26277760] [10.1016/j.bmc.2015.07.049]

Source